VARIZIG

STN: 125430
Proper Name: Varicella Zoster Immune Globulin
Tradename:VARIZIG
Manufacturer: Cangene Corporation
Indication:

• For postexposure prophylaxis in high risk individuals. High risk groups include:
  • immunocompromised children and adults,
  • newborns of mothers with varicella shortly before or after delivery,
  • premature infants,
  • infants less than one year of age,
  • adults without evidence of immunity,
  • pregnant women.

Product Information

• Package Insert-VARIZIG

Supporting Documents

• Approval History, Letters, Reviews, and Related Documents - VARIZIG
• Supporting Documents older than three years - VARIZIG